Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Orchid Pharma Limited's balance sheet to measure how much of total assets are equity-financed.

Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2026)

This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Orchid Pharma Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SFA Semicon Co. Ltd
KQ:036540
-0.016x
Invesco Municipal Trust
NYSE:VKQ
0.022x
Ipek Dogal Enerji Kaynaklari Arastirma ve Uretim AS
IS:IPEKE
-0.012x
Electronics Mart India Limited
NSE:EMIL
0.167x
Ningbo Sinyuan ZM Technology Co. Ltd. A
SHE:301398
N/A
Sharda Motor Industries Limited
NSE:SHARDAMOTR
0.127x
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
-0.068x
PIERER Mobility AG
VI:PKTM
0.049x

Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Orchid Pharma Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs12.88 Billion
≈ $139.27 Million
Rs1.10 Billion
≈ $11.88 Million
0.085x +462.76%
2025-03-31 Rs12.67 Billion
≈ $137.05 Million
Rs192.15 Million
≈ $2.08 Million
0.015x -85.93%
2024-03-31 Rs11.69 Billion
≈ $126.47 Million
Rs1.26 Billion
≈ $13.63 Million
0.108x +304.58%
2023-03-31 Rs6.89 Billion
≈ $74.47 Million
Rs183.38 Million
≈ $1.98 Million
0.027x -81.36%
2022-03-31 Rs6.47 Billion
≈ $70.01 Million
Rs924.75 Million
≈ $10.00 Million
0.143x +295.42%
2021-03-31 Rs6.53 Billion
≈ $70.61 Million
Rs235.86 Million
≈ $2.55 Million
0.036x -65.76%
2020-03-31 Rs7.66 Billion
≈ $82.84 Million
Rs808.03 Million
≈ $8.74 Million
0.105x +717.65%
2019-03-31 Rs-7.04 Billion
≈ $-76.14 Million
Rs120.24 Million
≈ $1.30 Million
-0.017x -47.30%
2018-03-31 Rs-7.92 Billion
≈ $-85.63 Million
Rs91.81 Million
≈ $992.84K
-0.012x +98.65%
2017-03-31 Rs-4.67 Billion
≈ $-50.48 Million
Rs4.01 Billion
≈ $43.36 Million
-0.859x -119.85%
2016-03-31 Rs490.45 Million
≈ $5.30 Million
Rs2.12 Billion
≈ $22.95 Million
4.327x +679.20%
2015-03-31 Rs3.29 Billion
≈ $35.62 Million
Rs-2.46 Billion
≈ $-26.61 Million
-0.747x -353.59%
2013-03-31 Rs3.81 Billion
≈ $41.16 Million
Rs1.12 Billion
≈ $12.12 Million
0.295x -52.70%
2012-03-31 Rs11.83 Billion
≈ $127.98 Million
Rs7.37 Billion
≈ $79.71 Million
0.623x +100.87%
2011-03-31 Rs10.71 Billion
≈ $115.84 Million
Rs3.32 Billion
≈ $35.92 Million
0.310x +947.20%
2010-03-31 Rs9.38 Billion
≈ $101.40 Million
Rs-343.17 Million
≈ $-3.71 Million
-0.037x -150.53%
2009-03-31 Rs6.34 Billion
≈ $68.54 Million
Rs459.01 Million
≈ $4.96 Million
0.072x -77.10%
2008-03-31 Rs6.65 Billion
≈ $71.92 Million
Rs2.10 Billion
≈ $22.74 Million
0.316x +63.88%
2007-03-31 Rs4.85 Billion
≈ $52.46 Million
Rs936.11 Million
≈ $10.12 Million
0.193x +1627.98%
2006-03-31 Rs7.76 Billion
≈ $83.88 Million
Rs-97.95 Million
≈ $-1.06 Million
-0.013x -106.68%
2005-03-31 Rs4.61 Billion
≈ $49.83 Million
Rs870.92 Million
≈ $9.42 Million
0.189x +667.99%
2004-03-31 Rs4.10 Billion
≈ $44.38 Million
Rs-136.54 Million
≈ $-1.48 Million
-0.033x --

About Orchid Pharma Limited

NSE:ORCHPHARMA India Drug Manufacturers - Specialty & Generic
Market Cap
$541.13 Million
Rs50.04 Billion INR
Market Cap Rank
#11639 Global
#586 in India
Share Price
Rs986.55
Change (1 day)
-1.37%
52-Week Range
Rs482.45 - Rs1101.40
All Time High
Rs2527.90
About

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more